University of Vermont

Clinical Simulation Laboratory

Bio for Ted A. James, MD, MS, FACS
Ted A. James, MD, MS, FACS

Ted A. James, MD, MS, FACS

Director of Clinical Simulation
Professor of Surgery
Division of Surgical Oncology

Contact Information
Office Location:
Surgery - Oncology, Given B227


Drexel University/Medical College of Pennsylvania, Philadelphia, PA, 1992-1996
Surgery Internship, North Shore University Hospital 1996-1997
Surgery Research Fellowship in Molecular Biology/Cellular Engineering, Boas Marks Medical Research Center, Manhasset, NY, 1997-1998
Residency in General Surgery, North Shore University Hospital, Manhasset, NY, 1999-2003
Fellowship in Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY, 2003-2005
Master of Science in Health Care Management, Harvard University School of Public Health,  2011-2013

Academic Appointments

Director of Clinical Simulation, Department of Surgery, College of Medicine, University of Vermont, Burlington, VT  2012-present
Associate Professor, Department of Surgery, College of Medicine, University of Vermont, Burlington, VT   2011-present
Assistant Professor, Department of Surgery, College of Medicine, University of Vermont, Burlington, VT   2005- 2010

Research Grants

New York University School of Medicine     1/7/10-12/31/10
Randomized Trial of Educational Outcomes of Web Initiative
 in surgical education. Proposal #: 24125.
Amount: $3,991. Role: Local PI

National Institute of Health (NCI Challenge Grant)    9/30/09-8/31/11
‘Improving breast cancer surgery quality through a collaborative
 surgery database’
Grant Number: 1RC1CA145402-01.
Amount: $1,280,221. Role: Local PI: 5%
National Institute of Health (National Cancer Institute)    9/30/09-7/31/11
‘Measuring quality of breast cancer surgery’
Amount: $3,141,962. Role: Co-Investigator: 10%
Dept. of Health and Human Resources (HRSA Grant)    9/1/09-8/31/10
‘Simulation scenario development’
Amount: $471,240.00. Role: Co-investigator: 10%

Vermont Experimental Program to Stimulate Competitive Research  10/1/08-6/1/09
‘Delivery of chemotherapeutic agents to human malignant melanoma cells
   using nanoporous silica particles’ (SBIR phase 0)
Amount: $12,000. Role: Principle Investigator.

Vermont Experimental Program to Stimulate Competitive Research  10/1/08-6/1/09
‘Evaluation of FTIR spectroscopy for breast cancer diagnosis
   and molecular characterization’ (SBIR phase 0)
Amount: $12,000. Role: Co-investigator/Clinical Consultant.

National Institute of Health (National Cancer Institute)    8/1/06-8/31/09 
‘Breast cancer stamp fund: molecular epidemiology and biology
   of mammographic density: A pilot study to evaluate protocol feasibility’
Role: Clinical Consultant

Small Business Technology Transfer Grant     10/07-09/09
Improving the transfer of ERK siRNA constructs using
   nanoporous silica. Apollo SRI, LLC / University of Vermont
Role: Clinical Consultant

University of Vermont - Department of Surgery Research Grant    7/1/06-7/1/08
‘Nanoporous particles as molecular delivery agents in melanoma’
Amount: $10,850. Role: Principal Investigator

University of Vermont - Department of Surgery Research Grant   7/1/06-7/1/08
‘Novel prognostic and diagnostic markers in human melanoma’
Amount $12,104. Role: Principal Investigator

Awards and Honors

Research Fellowship Sponsor (Medical Student: S. Persing)   2010
University of Vermont, College of Medicine

Jerome S. Abrams Teaching Award       2009
Department of Surgery, University of Vermont

Cancer Liaison Physician Outstanding Performance Award   2008
Commission on Cancer

Leadership Scholarship Award  2008
American College of Surgeons 

Thoracic Surgery Oncology Fellowship Award  2005
Roswell Park Cancer Institute


Kaiser S, Vassell R, Pinckney RG, Holmes TE, James TA.  Clinical impact of biopsy method on the quality of surgical management in melanoma. J Surg Oncol. 2014 Jun;109(8):775-9.

Bolton KC, Mace JL, Vacek PM, Herschorn SD, James TA, Tice JA, Kerlikowske K, Geller BM, Weaver DL, Sprague BL. Changes in breast cancer risk distribution among Vermont women using screening mammography. J Natl Cancer Inst. 2014 Jun 23;106(8).

Sprague BL, Bolton KC, Mace JL, Herschorn SD, James TA, Vacek PM, Weaver DL, Geller BM. Registry-based Study of Trends in Breast Cancer Screening Mammography before and after the 2009 U.S. Preventive Services Task Force Recommendations. Radiology. 2014 Feb;270(2):354-61.

Lynge E, Ponti A, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Frigerio A, Kawai M, Scharpantgen A, Broeders M, Hofvind S, Vidal C, Ederra M, Salas D, Bulliard JL, Tomatis M, Kerlikowske K, Taplin S; ICSN DCIS Working group. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network. Eur J Cancer. 2014 Jan;50(1):185-92.

Onitilo AA, Onesti JK, Single RM, Engel JM, James TA, Aiello Bowles EJ, Feigelson HS, Barney T, McCahill LE. Utilization of neoadjuvant chemotherapy varies in the treatment of women with invasive breast cancer. PLoS One. 2013 Dec 20;8(12):e84535.

Yarger JB, James TA, Ashikaga T, Hayanga AJ, Takyi V, Lum Y, Kaiser H, Mammen J. Characteristics in response rates for surveys administered to surgery residents. Surgery 2013 Jul;154(1):38-45.

Feigelson HS, James TA, Single RM, Onitilo AA, Aiello Bowles EJ, Barney T, Bakerman JE, McCahill LE. Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study. J Am Coll Surg. 2013 May;216(5):966-75.

James TA, Mace JL, Virnig BA, Geller BM. Preoperative needle biopsy improves the quality of breast cancer surgery. J Am Coll Surg 2012;215(4):562-8.

Aiello Bowles EJ, Feigelson HS, Barney T, Broecker K, Sterrett A, Bischoff K, Engel J, Gundersen G, Sheehey-Jones J, Single R, Onitilo A, James TA, McCahill LE. Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database. BMC Cancer. 2012;12:136.

McCahill LE, Single RM, Aiello Bowles EJ, Feigelson HS, James TA, Barney T, Engel JM, Onitilo AA. Variability in reexcision following breast conservation surgery. JAMA. 2012;307(5):467-75.

Persing S, James TA, Mace J, Geller B. Variability in the quality of pathology reporting of margin status following breast cancer surgery. Ann Surg Oncol 2011;18:(11):3061-5.

Dr. James' Publications in PubMed